Abstracts
Showing 800 abstracts.
Inflammatory and Coagulation Biomarker Trajectories from Late Pregnancy to Six Weeks Postpartum in HIV-infected Women who Continue versus Discontinue Antiretroviral Therapy after Delivery
Strong influence of CYP2B6 Genotypic Polymorphisms (Geno) on Efavirenz (EFV) Pharmacokinetics (PK) in HIV-infected (HIV+) Children <3 years of Age: Implications for an EFV Dosing Approach in Young Children
Study
P1070
Low Darunavir (DRV) and Etravirine (ETR) Exposure When Used in Combination in HIV-Infected Children and Adolescents
Study
P1058A
Predictors of Virologic and Clinical Response to Nevirapine (NVP) vs Lopinvavir/Ritonavir (LPV/r)-Based Antiretroviral Therapy (ART) in Infants and Children With and Without Prior NVP Exposure for the Prevention of Mother-to-Child HIV Transmission (PMTCT)
Study
P1060
Factors Associated with Lack of Viral Suppression at Delivery in the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) P1025
Study
P1025
Emergence of nevirapine (NVP) resistance in HIV-infected infants exposed to NVP for prevention of mother-to-child transmission and treatment of maternal HIV infection: HIV Prevention Trials Network 046 study
Age-Related Differences in Plasma and Intracellular (IC) Tenofovir (TFV) Concentrations
Immunological Recovery in HIV-Infected Children: Differences by Baseline CD4% and Age
Early non-adherence to study drug associated with increased risk of TB in both INH and placebo groups in P1041
Study
P1041